当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 现金流量表

安图生物

(603658)

  

流通市值:194.74亿  总市值:194.74亿
流通股本:5.71亿   总股本:5.71亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,350,992,101.121,189,097,872.314,702,576,301.333,420,516,955.89
  收到的税费返还3,306,407.04773,234.8621,408,259.9815,518,648.51
  收到其他与经营活动有关的现金68,289,117.0640,724,021.7195,252,223.18145,726,926.86
  经营活动现金流入小计2,422,587,625.221,230,595,128.874,919,236,784.493,581,762,531.26
  购买商品、接受劳务支付的现金875,490,223.45363,392,484.111,467,448,287.221,076,737,751.87
  支付给职工以及为职工支付的现金721,072,379.93475,721,428.361,159,015,933.18916,538,119.4
  支付的各项税费321,510,192.5126,410,106.27487,966,552.96375,636,923.81
  支付其他与经营活动有关的现金288,672,868.31118,498,609.63463,124,248.38367,427,922.79
  经营活动现金流出小计2,206,745,664.191,084,022,628.373,577,555,021.742,736,340,717.87
  经营活动产生的现金流量净额215,841,961.03146,572,500.51,341,681,762.75845,421,813.39
二、投资活动产生的现金流量:
  收回投资收到的现金6,745,925.693,450,961.66--
  取得投资收益收到的现金2,235,8702,235,870894,348894,348
  处置固定资产、无形资产和其他长期资产收回的现金净额7,000-109,282.3109,282.3
  收到的其他与投资活动有关的现金6,027,008,639.792,222,136,910.874,979,269,563.554,039,062,461.62
  投资活动现金流入小计6,035,997,435.482,227,823,742.534,980,273,193.854,040,066,091.92
  购建固定资产、无形资产和其他长期资产支付的现金226,813,702.18133,159,505.15604,302,271.16464,971,414.97
  投资支付的现金88,499,49488,499,49417,500,0007,500,000
  支付其他与投资活动有关的现金4,461,233,511.331,836,927,142.314,773,821,435.963,329,162,589.43
  投资活动现金流出小计4,776,546,707.512,058,586,141.465,395,623,707.123,801,634,004.4
  投资活动产生的现金流量净额1,259,450,727.97169,237,601.07-415,350,513.27238,432,087.52
三、筹资活动产生的现金流量:
  吸收投资收到的现金--14,455,00014,455,000
  其中:子公司吸收少数股东投资收到的现金--14,455,00014,455,000
  取得借款收到的现金3,042,046.613,000,000364,670,786.89361,670,786.89
  收到其他与筹资活动有关的现金845,010,000160,850,0001,639,509,118.121,206,334,001.7
  筹资活动现金流入小计848,052,046.61163,850,0002,018,634,905.011,582,459,788.59
  偿还债务支付的现金--852,670,786.89852,670,786.89
  分配股利、利润或偿付利息支付的现金751,647,626.15283,730.83728,785,691.1728,357,690.12
  其中:子公司支付给少数股东的股利、利润2,004,100-2,102,1002,102,100
  支付其他与筹资活动有关的现金895,610,578.28265,573,745.221,233,471,317.45947,974,071.45
  筹资活动现金流出小计1,647,258,204.43265,857,476.052,814,927,795.442,529,002,548.46
  筹资活动产生的现金流量净额-799,206,157.82-102,007,476.05-796,292,890.43-946,542,759.87
四、汇率变动对现金及现金等价物的影响-17,706,566.05-7,662,969.99774,015.752,418,501.37
五、现金及现金等价物净增加额658,379,965.13206,139,655.53130,812,374.8139,729,642.41
  加:期初现金及现金等价物余额582,870,723.61582,870,723.61452,058,348.81452,058,348.81
  期末现金及现金等价物余额1,241,250,688.74789,010,379.14582,870,723.61591,787,991.22
补充资料:
  净利润502,204,100.87-1,086,384,222.05-
  资产减值准备-536,333.46-19,708,750.29-
  固定资产和投资性房地产折旧202,021,045.69-427,857,927.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧202,021,045.69-427,857,927.85-
  无形资产摊销16,687,046.24-28,181,990.29-
  长期待摊费用摊销15,671,432.51-27,694,870.94-
  处置固定资产、无形资产和其他长期资产的损失---637,786.38-
  固定资产报废损失2,574,068.07-4,965,505.65-
  公允价值变动损失-28,802.44-3,495,613.67-
  财务费用13,663,464.09-15,562,007.36-
  投资损失-29,718,977.45--104,506,851.42-
  递延所得税-13,351,807.44--51,008,060.49-
  其中:递延所得税资产减少-28,286,424.28--13,546,443.34-
    递延所得税负债增加14,934,616.84--37,461,617.15-
  存货的减少-297,211,057.82--284,740,441.26-
  经营性应收项目的减少-6,270,958.79-30,432,966.6-
  经营性应付项目的增加-213,041,177.14-129,163,358.86-
  其他19,379,412.19--8,262,674.71-
  现金的期末余额1,241,250,688.74-582,870,723.61-
  减:现金的期初余额582,870,723.61-452,058,348.81-
  现金及现金等价物的净增加额658,379,965.13-130,812,374.8-
公告日期2026-08-252026-04-232026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑